SNES
SNES
NASDAQ · Pharmaceuticals

Senestech Inc

$1.29
+0.02 (+1.57%)
As of Aug 8, 10:57 PM ET ·
Financial Highlights (FY 2026)
Revenue
3.54M
Net Income
-10,182,893
Gross Margin
62.5%
Profit Margin
-287.4%
Rev Growth
+29.6%
D/E Ratio
0.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 62.5% 62.5% 62.8% 62.8%
Operating Margin -292.9% -263.6% 42.6% 41.5%
Profit Margin -287.4% -273.0% 36.3% 33.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.54M 2.73M 1.47M 1.59M
Gross Profit 2.21M 1.71M 923.2K 998.4K
Operating Income -10,378,325 -7,206,614 625.4K 659.9K
Net Income -10,182,893 -7,070,907 533.2K 527.1K
Gross Margin 62.5% 62.5% 62.8% 62.8%
Operating Margin -292.9% -263.6% 42.6% 41.5%
Profit Margin -287.4% -273.0% 36.3% 33.2%
Rev Growth +29.6% +29.6% +11.3% -5.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 72.6K 72.6K 2.27M 1.95M
Total Equity 3.38M 3.38M 4.98M 4.41M
D/E Ratio 0.02 0.02 0.46 0.44
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -10,199,094 -7,475,610 838.1K 900.8K
Free Cash Flow 521.2K 519.7K